BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8472774)

  • 1. Different seroprevalences of antibodies against Neisseria meningitidis serogroup A and Haemophilus influenzae type b in Sudanese and Swedish children.
    Salih MA; Fredlund H; Hugosson S; Bodin L; Olcén P
    Epidemiol Infect; 1993 Apr; 110(2):307-16. PubMed ID: 8472774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum factors and polymorphonuclear leukocytes in human host defence against Neisseria meningitidis. Studies of interactions with special reference to a chemiluminometric technique.
    Fredlund H
    Scand J Infect Dis Suppl; 1993; 87():1-72. PubMed ID: 8511525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood acute bacterial meningitis in the Sudan: an epidemiological, clinical and laboratory study.
    Salih MA
    Scand J Infect Dis Suppl; 1990; 66():1-103. PubMed ID: 2115207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays: towards an improved surveillance of meningococcal disease.
    Andersen J; Berthelsen L; Lind I
    Clin Diagn Lab Immunol; 1997 May; 4(3):345-51. PubMed ID: 9144375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease.
    Käyhty H; Jousimies-Somer H; Peltola H; Mäketä PH
    J Infect Dis; 1981 Jan; 143(1):32-41. PubMed ID: 6783703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
    Dolan KT; Staub JM; Schofield TL; Ahonkhai VI; Ellis RW; Vella PP
    J Immunoassay; 1991; 12(4):543-64. PubMed ID: 1806588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the serum antibody response to the capsular polysaccharide of Haemophilus influenzae type b in children with invasive infections.
    Trollfors B; Lagergård T; Claesson BA; Thornberg E; Martinell J; Schneerson R
    J Infect Dis; 1992 Dec; 166(6):1335-9. PubMed ID: 1431250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based seroprevalence of Neisseria meningitidis serogroup C capsular antibody before the introduction of conjugate vaccine, in Australia.
    Backhouse JL; Gidding HF; MacIntyre CR; McIntyre PB; Gilbert GL
    Vaccine; 2007 Jan; 25(7):1310-5. PubMed ID: 17069937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive infections caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae among children in St Petersburg, Russia.
    Kaijalainen T; Kharit SM; Kvetnaya AS; Sirkiä K; Herva E; Parkov OV; Nohynek H
    Clin Microbiol Infect; 2008 May; 14(5):507-10. PubMed ID: 18318743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do we need a booster of Hib vaccine after primary vaccination? A study on anti-Hib seroprevalence in Sweden 5 and 15 years after the introduction of universal Hib vaccination related to notifications of invasive disease.
    Hallander HO; Lepp T; Ljungman M; Netterlid E; Andersson M
    APMIS; 2010 Nov; 118(11):878-87. PubMed ID: 20955461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interim report of a controlled field trial of immunization with capsular polysaccharides of Haemophilus influenzae type b and group C Neisseria meningitidis in Mecklenburg county, North Carolina (March 1974-March 1976).
    Parke JC; Schneerson R; Robbins JB; Schlesselman JJ
    J Infect Dis; 1977 Aug; 136 Suppl():S51-6. PubMed ID: 408433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992.
    Holder PK; Maslanka SE; Pais LB; Dykes J; Plikaytis BD; Carlone GM
    Clin Diagn Lab Immunol; 1995 Mar; 2(2):132-7. PubMed ID: 7697519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis for protection rate and antibody levels of epidemic cerebrospinal meningitis among children aged between 3-23 months in Liuzhou, in 2012].
    Cui XL; Wu X; Li MQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1079-1083. PubMed ID: 28057112
    [No Abstract]   [Full Text] [Related]  

  • 15. Mucosal antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Gilsdorf JR; McDonnell WM
    Pediatr Res; 1991 May; 29(5):420-3. PubMed ID: 1896245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
    Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
    Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study.
    Martin NG; Sadarangani M; Pollard AJ; Goldacre MJ
    Lancet Infect Dis; 2014 May; 14(5):397-405. PubMed ID: 24631222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies prevalence against Haemophilus influenzae type b in Jeddah population, Saudi Arabia. I. Total antibodies.
    Zarei AE; Redwan EM
    Hum Antibodies; 2018; 26(4):225-235. PubMed ID: 29945350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age.
    Peltola H; Mäkelä H; Käyhty H; Jousimies H; Herva E; Hällström K; Sivonen A; Renkonen OV; Pettay O; Karanko V; Ahvonen P; Sarna S
    N Engl J Med; 1977 Sep; 297(13):686-91. PubMed ID: 408682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of low-avidity antibody by infants after infection with serogroup B meningococci.
    Pollard AJ; Levin M
    Lancet; 2000 Dec; 356(9247):2065-6. PubMed ID: 11145494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.